Precigen, Inc. (PGEN) Income Statement
PGEN 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsPGEN revenue and net income
Where PGEN's revenue goes
2025Each bar shows an amount and its share of revenue. PGEN kept −2,588.2% of revenue as net income.
PGEN profit margins
PGEN growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +146.7% | −28.9% | −21.3% | −25.1% |
| Gross profit | — | −44.1% | — | −29.0% |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
PGEN quarterly EPS vs estimates
Precigen beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: November 12, 2026 (estimate $0.09).
PGEN income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.7M | $3.9M | $6.2M | $26.9M | $14.3M | $32.0M | $32.0M | $160.6M | $231.0M | $190.9M |
| Cost of revenue | $6.1M | $4.3M | $6.1M | $6.3M | $53.7M | $44.8M | $5.4M | $63.3M | $62.8M | $61.6M |
| Gross profit | $3.6M | −$342,000 | $106,000 | $20.6M | −$39.4M | −$12.8M | $26.6M | $97.3M | $168.2M | $129.3M |
| Research & development | $40.1M | $53.1M | $48.6M | $47.2M | $47.9M | $39.4M | $39.4M | $404.6M | $143.2M | $112.1M |
| Sales, general & admin | $70.1M | $41.3M | $40.4M | $48.0M | $74.1M | $91.7M | $100.8M | $137.8M | $146.1M | $142.3M |
| Total operating expenses | $110.2M | $134.7M | $99.9M | $96.3M | $52.5M | $73.5M | $112.9M | $542.4M | $289.3M | $254.5M |
| Operating income | −$106.6M | −$135.0M | −$99.8M | −$75.7M | −$91.9M | −$86.3M | −$86.3M | −$505.6M | −$137.9M | −$125.2M |
| Interest income | $3.2M | $1.4M | $3.2M | $133,000 | $1.6M | $2.5M | $3.9M | $19.1M | $19.5M | $10.2M |
| Interest expense | $3.9M | $6,000 | $468,000 | $6.8M | $18.8M | $18.4M | $18.2M | $8.5M | $611,000 | $861,000 |
| Income before taxes | −$250.6M | −$128.0M | −$96.4M | −$80.0M | −$111.0M | −$104.5M | −$104.5M | −$536.2M | −$129.7M | −$194.2M |
| Income taxes | $3,000 | −$1.8M | −$458,000 | −$189,000 | −$160,000 | −$82,000 | −$82,000 | −$21.5M | −$2.9M | −$3.9M |
| Net income | −$250.6M | −$126.2M | −$95.9M | $28.3M | −$92.2M | −$170.5M | −$170.5M | −$509.3M | −$117.0M | −$186.6M |
| EBITDA | −$243.6M | −$123.5M | −$89.2M | −$62.4M | −$77.6M | −$68.0M | −$68.8M | −$363.3M | −$97.9M | −$168.7M |
| EPS (diluted) | −$1.39 | −$0.33 | −$0.39 | −$0.33 | −$0.49 | −$1.02 | −$1.28 | −$3.86 | −$0.92 | −$1.17 |
| Gross margin | 37.1% | −8.7% | 1.7% | 76.4% | −276.2% | −40.0% | 83.2% | 60.6% | 72.8% | 67.7% |
| Operating margin | −1,100.8% | −3,440.2% | −1,602.5% | −281.4% | −644.5% | −269.8% | −269.8% | −314.9% | −59.7% | −65.6% |
| Net margin | −2,588.2% | −3,216.2% | −1,540.6% | 105.2% | −646.0% | −533.0% | −533.0% | −317.2% | −50.7% | −97.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $55.0M | $23.3M | $4.6M | $2.9M | $856,000 | $1.3M | $1.2M | $953,000 | $717,000 | $1.1M | $1.2M | $1.4M |
| Cost of revenue | $2.8M | $2.9M | $1.9M | $1.4M | $1.6M | $1.4M | $1.2M | $1.0M | $1.0M | $1.9M | $2.6M | $1.5M |
| Gross profit | $52.2M | $20.4M | $2.7M | $1.6M | −$699,000 | −$78,000 | $21,000 | −$56,000 | −$297,000 | −$810,500 | −$1.3M | −$158,000 |
| Research & development | $7.3M | $5.3M | $6.7M | $12.1M | $11.5M | $10.2M | $11.8M | $11.4M | $15.7M | $14.2M | $13.0M | $11.6M |
| Sales, general & admin | $22.2M | $21.0M | $17.6M | $24.0M | $16.1M | $12.4M | $11.0M | $9.8M | $10.3M | $10.2M | $10.3M | $9.2M |
| Total operating expenses | $29.5M | $26.4M | $24.3M | $36.0M | $31.1M | $22.5M | $28.5M | $21.2M | $60.5M | $23.6M | $22.1M | $20.8M |
| Operating income | $22.6M | −$6.0M | −$21.7M | −$34.5M | −$31.8M | −$22.6M | −$28.5M | −$21.3M | −$60.8M | −$24.4M | −$23.4M | −$20.9M |
| Interest income | $366,000 | $683,000 | $1.1M | $534,000 | $696,000 | $918,000 | $208,000 | $283,000 | $319,000 | $608,000 | $921,000 | $856,000 |
| Interest expense | $3.0M | $2.9M | $3.0M | $902,000 | $0 | $1,000 | $6,000 | $2,000 | $2,000 | $2,000 | $7,000 | $1,000 |
| Income before taxes | $20.1M | −$7.9M | −$23.5M | −$146.3M | −$26.6M | −$54.2M | −$19.8M | −$24.0M | −$60.5M | −$23.8M | −$33.4M | −$19.8M |
| Income taxes | — | — | $6,000 | $179.0M | $3,000 | −$87,000 | −$87,000 | $12,000 | −$1.7M | −$29,000 | −$332,000 | −$6,000 |
| Net income | $20.1M | −$7.9M | −$23.5M | −$146.3M | −$26.6M | −$54.2M | −$19.7M | −$24.0M | −$58.8M | −$23.7M | −$33.1M | −$19.8M |
| EBITDA | $24.1M | −$3.9M | −$19.4M | −$144.6M | −$27.2M | −$53.5M | −$19.2M | −$23.3M | −$58.9M | −$22.2M | −$31.8M | −$18.1M |
| EPS (diluted) | $0.05 | −$0.02 | −$0.07 | −$1.06 | −$0.08 | −$0.18 | −$0.04 | −$0.09 | −$0.10 | −$0.10 | −$0.13 | −$0.08 |
| Gross margin | 94.9% | 87.6% | 58.1% | 53.7% | −81.7% | −5.8% | 1.8% | −5.9% | −41.4% | −76.1% | −109.0% | −11.5% |
| Operating margin | 41.2% | −25.8% | −474.6% | −1,180.0% | −3,710.7% | −1,685.0% | −2,396.3% | −2,231.1% | −8,485.5% | −2,292.3% | −1,904.6% | −1,518.3% |
| Net margin | 36.5% | −34.1% | −514.9% | −5,008.4% | −3,112.4% | −4,038.3% | −1,657.7% | −2,516.1% | −8,199.7% | −2,228.9% | −2,691.9% | −1,435.5% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in PGEN's financial statements (latest annual report filed March 25, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
PGEN financial results
In fiscal year 2025 (ended December 31, 2025), Precigen reported revenue of $9.7 million, up 146.7% from the year before. It had a net loss of $250.6 million, a net profit margin of −2,588.2%. Diluted earnings per share came to −$1.39. Over five years revenue grew at an average rate of −21.3% a year.
See the PGEN stock overview for the latest quote and news, or the PGEN chart for price history and technical indicators.
PGEN income statement FAQ
What is Precigen's annual revenue?
Precigen reported total revenue of $9.7 million for fiscal year 2025, which ended on December 31, 2025. That was up 146.7% from $3.9 million the previous year.
Is Precigen profitable?
No. Precigen reported a net loss of $250.6 million in fiscal 2025, a net profit margin of −2,588.2%; its operating margin was −1,100.8%.
What is Precigen's gross margin?
Precigen's gross margin was 37.1% in fiscal 2025: for every $100 of revenue, Precigen kept $37 after the direct cost of its products and services.
How much does Precigen spend on research and development?
Precigen spent $40.1 million on research and development in fiscal 2025, 413.7% of revenue.
How fast is Precigen growing?
Revenue grew −21.3% a year on average over the last five fiscal years, from $32.0 million to $9.7 million.
What are Precigen's earnings per share?
Precigen earned $-1.39 per diluted share in fiscal 2025, compared with $-0.33 a year earlier.
When will Precigen report its next earnings?
Precigen is expected to report results for the quarter ending September 30, 2026 on November 12, 2026 after the market closes.
When does Precigen's fiscal year end?
Precigen's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 25, 2026.